News

Dr. Goodenowe presenting at Telomere Summit Jan 19

Dr. Goodenowe presents at the Telomere Summit on January 19th. His presentation is titled “What Are Plasmalogens? Critical Cell Membrane Components In Alzheimer’s and Cardiovascular Disorders”. The Telomere Summit is FREE to register for, and runs from January 18th to 25th. The event focuses on providing information to healthcare professionals to learn from the Global Experts on How Telomere Length is associated with Cognitive, Cardiovascular, and other major organ systems in the Human body, and how to incorporate this into practice.  Register for free here.

Read More »

Dr. Goodenowe presenting at A4M Conference

Dr. Goodenowe presents at the A4M 29th Annual World Congress this Saturday, December 11 at 2pm. His presentation is titled “Plasmalogen Therapy Improves Cognition, and Mobility – The Science and Clinical Results – What Every Longevity Practitioner Needs to Know”.  Aside from Dr. Goodenowe being an invited speaker, our team will be in attendance and will have a booth set up.  Learn more here.

Read More »

Dr. Goodenowe Presentation

Dr. Goodenowe presents a special presentation on skin health titled “Aging, plasmalogens, and the biochemistry of skin: New insights and strategies for maintaining healthy skin from the inside out” at the SSRP Beverly Hills Aesthetics Summit Oct 15-16, 2021. Learn more here.

Read More »

We Gotta Talk with Sonni live interview

Thank you to Sonni Abatta for interviewing Dr. Dayan Goodenowe, Founder and CEO of Prodrome Sciences, live on her podcast to discuss many exciting topics including plasmalogen research, brain health, Alzheimer’s disease, Parkinson’s disease, longevity, and more. Listen here.

Read More »

Dr. Seeds podcast interview

Thank you to Dr. Seeds for hosting Dr. Goodenowe on the Sex, Drugs, & Epigenome Podcast where they discussed Dr. Goodenowe’s new book Breaking Alzheimer’s and the importance of plasmalogen supplementation. Listen here. 

Read More »

Dr. Goodenowe invited to speak at SSRP Brain Summit

Dr. Dayan Goodenowe has been invited to speak at the Seeds Scientific Research & Performance (SSRP) Dallas Brain Summit. Dr. Goodenowe will share his expertise at the event focused on cognitive function, optimization, and neurological disease. The event is August 20 – 21 and attendance is in person or virtual. Register here.

Read More »

DNA Today podcast interview

It was a pleasure to speak to host Kira Dineen on her Podcast, DNA Today, which won the Best 2020 Science & Medicine Podcast award. Dr. Dayan Goodenowe and Kira discuss: Dementia vs Alzhiemer’s disease APOE gene’s role in Alzheimer’s disease Methods to counteract APOE status Correlation between plasmalogens and dementia Plasmalogen’s blood vs brain levels ProdromeNeuro for Alzheimer’s Disease and Parkinson’s Disease Listen to the podcast here.

Read More »

Breaking Alzheimer’s – The Definitive Lecture Series launches today

Dr. Dayan Goodenowe, Founder and CEO of Prodrome Sciences, created Breaking Alzheimer’s: The Definitive Lecture Series as a detailed scientific treatise to continue the awakening process that he began in Breaking Alzheimer’s – The Book. The Definitive Lecture Series is designed to provide a full and complete understanding of the key aspects of brain health changes that are associated with Alzheimer’s disease and cognition. In each lecture, Dr. Goodenowe explains the relevant research and literature of each topic. The lectures integrate Dr. Goodenowe’s own research and over 50 years of research from leading researchers from around the world.   The series

Read More »

PRESS RELEASE: ProdromeNeuro plasmalogen supplement improved cognition in recent clinical trial

Breaking Alzheimer’s the book: from scientific detective story to improved cognition in recent clinical trial using ProdromeNeuroTM plasmalogen supplement Temecula, CA, August 3, 2021 – ProdromeNeuroTM plasmalogen supplement successfully improved cognition and mobility in a recent Alzheimer’s disease clinical trial, proving Dr. Dayan Goodenowe’s 15-year theory outlined in his new book Breaking Alzheimer’s where he explains his scientific journey to expose the cause and deliver the cure. Prodrome Sciences launched the world’s first high-dose plasmalogen supplement, ProdromeNeuro, last year. A clinical trial was initiated shortly thereafter. The clinical trial results were released at the Alzheimer’s Association International Conference on July

Read More »